Repertoire^® Immune Medicines Enters New Research Collaboration to Discover the T Cell Response to Therapy in HPV-Associated Cancers

Repertoire Immune Medicines announced its research collaboration with Memorial Sloan Kettering Cancer Center to identify the immune system’s response at various stages of human papillomavirus-positivecancer, including initial oncogenesis and after successful treatment.